Find an Alzheimer's clinical trial

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Search title, drug, condition or sponsor

Recruiting

Exact registry status

Phase

Intervention class

Study type

Country

Results per page

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,376–6,400 of 7,816 matching trials · page 256 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial	Phase	Status	Enrolled	Sponsor	Last updated
Florbetapir Calibration to the Centiloid Scale NCT02120664 Florbetapir (18F); 11C-PiB Runs in: Australia; United States · 2 sites	PHASE1 other	COMPLETED	35	Avid Radiopharmaceuticals INDUSTRY	2017-03-09
A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease NCT01404169 E2020; Placebo Runs in: China · 32 sites	PHASE3 symptomatic-cholinergic	COMPLETED	260	Eisai Limited INDUSTRY	2017-03-08
Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's Disease NCT02370524 [18F]T807 Runs in: United States · 1 site	PHASE1 other	COMPLETED	16	Molecular NeuroImaging OTHER	2017-03-08
A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients NCT02158910 Aricept Runs in: South Korea · 13 sites	NA other	COMPLETED	2,231	Eisai Korea Inc. INDUSTRY	2017-03-07
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease NCT02017340 Nilvadipine; Placebo Runs in: France; Germany; Greece; Hungary; Ireland; Italy; Netherl... · 23 sites	PHASE3 other	COMPLETED	511	Prof Brian Lawlor OTHER	2017-03-06
Therapy of Alzheimer's Disease With Neurofeedback NCT03070821 rtfMRI neurofeedback training; 3T MRI	NA other	COMPLETED	30	University Hospital, Aachen OTHER	2017-03-06
ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit NCT01270269 Behavioral: Physical and functional rehabilitation; Behavioral: Cog... Runs in: United States · 1 site	NA other	COMPLETED	87	Vanderbilt University OTHER	2017-03-03
Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old NCT02198586 Runs in: Spain · 1 site	NA other	COMPLETED	575	Barcelonabeta Brain Research Center, Pasqual Maragall Foundation OTHER	2017-03-03
An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population NCT02249468 Runs in: Singapore · 1 site	NA other	TERMINATED	191	Danone Nutricia Research INDUSTRY	2017-03-03
Magnetic Resonance Imaging-based Comparative Research in Different Mild Cognitive Impairment Subtype NCT02706210 Runs in: China · 1 site	NA other	UNKNOWN	160	Mudanjiang Medical University OTHER	2017-03-01
Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients NCT01602198 Exelon [rivastigmine] transdermal patch; Placebo transdermal patch Runs in: United States · 1 site	NA symptomatic-cholinergic	TERMINATED	1	The Cleveland Clinic OTHER	2017-02-28
Effect of Melatonin on Sleep Quality in Patients Dementia NCT03066518 Melatonin 5 mg; Placebo	PHASE4 other	COMPLETED	40	Hospital Universitario Dr. Jose E. Gonzalez OTHER	2017-02-28
Comparative Research of Alzheimer's Disease Drugs NCT01362686 Donepezil; Galantamine; Rivastigmine Runs in: United States · 5 sites	NA symptomatic-cholinergic	TERMINATED	200	Indiana University OTHER	2017-02-27
A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease NCT01047579 Rivastigmine transdermal Runs in: Israel · 5 sites	PHASE4 symptomatic-cholinergic	COMPLETED	51	Novartis Pharmaceuticals INDUSTRY	2017-02-24
An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease NCT00219232 Rivastigmine Transdermal Patch	PHASE3 symptomatic-cholinergic	COMPLETED	868	Novartis INDUSTRY	2017-02-23
Caregiver Stress: Interventions to Promote Health and Wellbeing NCT01188070 Usual Care; Psycho-education; Psycho-education plus physical exercise Runs in: United States · 1 site	NA other	COMPLETED	354	Emory University OTHER	2017-02-23
Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease NCT01193608 AAB-003 (PF-05236812); AAB-003 (PF-05236812); AAB-003 (PF-05236812)... Runs in: South Korea; United States · 29 sites	PHASE1 other	COMPLETED	88	Pfizer INDUSTRY	2017-02-23
Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's NCT02502045 Morning Simulated Sunlight; Non-therapeutic Red Light Runs in: United States · 1 site	NA other	COMPLETED	18	Yale University OTHER	2017-02-20
An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders NCT00308074 Aripiprazole Runs in: United States · 1 site	PHASE2 other	COMPLETED	14	Cambridge Health Alliance OTHER	2017-02-15
Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropscyhiatric Symptoms NCT02655003 TIME; Education-only intervention Runs in: Norway · 1 site	NA other	COMPLETED	229	Sykehuset Innlandet HF OTHER	2017-02-15
Changing Talk to Reduce Resistiveness to Care NCT01324219 Staff; Resident Runs in: United States · 1 site	NA other	COMPLETED	202	University of Kansas Medical Center OTHER	2017-02-13
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients NCT01948791 ENA713 Runs in: China · 1 site	PHASE4 other	COMPLETED	222	Novartis Pharmaceuticals INDUSTRY	2017-02-13
Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. NCT00488319 Paliperidone ER Runs in: Belgium; Bulgaria; Estonia; Finland; India; Poland; Roman... · 53 sites	PHASE3 other	COMPLETED	400	Janssen Research & Development, LLC INDUSTRY	2017-02-10
RIVastigmine In Vascular cognitivE Impairment NCT00669344 Exelon (rivastigmine); Placebo Runs in: Singapore · 1 site	PHASE4 symptomatic-cholinergic	COMPLETED	50	Singapore General Hospital OTHER	2017-02-10
A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment NCT01548287 AZD5213; AZD5213; AZD5213; Placebo Runs in: United States · 13 sites	PHASE2 other	COMPLETED	164	AstraZeneca INDUSTRY	2017-02-07

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry: ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file: 7,816
Source file: trials.csv (3.8 MB, 7816 rows)
Basis: Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024 · score 88/100
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial The Lancet. Neurology, 2026 · score 86/100
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial Lancet (London, England), 2021 · score 86/100
Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease Journal of Alzheimer's disease : JAD, 2026 · score 86/100
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial EBioMedicine, 2024 · score 85/100

All 162 studies on Clinical trials →